Rare Disease and Orphan Drugs Journal (RDODJ) is an international peer-reviewed, open access, online journal.
Aims and Scope
The Rare Disease and Orphan Drugs Journal (RDODJ) is an international, peer-reviewed, open access journal for the publication of innovative research works on various aspects of this rapidly growing multidisciplinary and interdisciplinary field.
RDODJ will report on scientific advances in the genetics of rare diseases, the molecular basis of the pathologies, and translational research on diagnosis, prevention and treatment.
In addition, RDODJ aims to provide a forum for scientific studies and discussion covering the important regulatory, socio-economic and human science issues related to rare diseases and orphan drugs.
The ultimate objective of RDODJ is to promote the dissemination of research results and scientific discussion among the research community, practitioners, and patient-advocacy organizations.
The scope of RDODJ covers the following research topics:
- Genetics of rare diseases. Non-genetic rare diseases, rare cancers, tropical rare diseases
- Diagnosis and undiagnosed rare diseases
- Epidemiology, registries, data bases, and artificial intelligence
- Pathophysiological mechanism. Biochemistry and cell biology
- Protein, gene, and cell therapy. Precision medicine and genome editing
- Drug repurposing and delivery
- Preclinical translational research. Clinical research and methodology
- Regulatory and practice guidelines
- Medico-economic, health policies and services organization and health promotion
- Social sciences: patients' needs, quality of life.
The journal is owned by OAE Publishing Inc.
Gold open access. All articles published by RDODJ are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.
Copyright and License to Publish
Articles in RDODJ are published under a Creative Commons Attribution 4.0 International (CC BY 4.0). The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting RDODJ, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.
For more information about the editorial team, please refer to Editorial Board.
All manuscripts submitted to RDODJ should adhere to RDODJ's Editorial Policies.
Publication Ethics Statement
The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of RDODJ take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.
Journal Information and Statistics
- Frequency: Quarterly published
- DOI: 10.20517/rdodj
- Digital archive: Portico
- ISSN 2771-2893 (Online)
Indexing & ArchivingAll articles published in RDODJ are included in:
Please visit Contact Us for details about different queries.